Area of research
Pulmonary and Respiratory Medicine · Epidemiology
Research interest
Research interests include Radiation Therapy and Dosimetry, Meningioma and schwannoma management, Effects of Radiation Exposure, and Neurofibromatosis and Schwannoma Cases.
First in vitro and in vivo experiments with ultra high-dose rate oxygen ion radiotherapy
Spatio-temporal transcriptomics of chromothriptic SHH-medulloblastoma identifies multiple genetic clones that resist treatment and drive relapse
Ultrahigh Dose Rate Helium Ion Beams: Minimizing Brain Tissue Damage while Preserving Tumor Control
Personalized Medicine for Meningiomas: Drug Screening on Tumor Organoids Exposes Therapeutic Vulnerabilities to HDAC1/2i Panobinostat
Ultra-High Dose Rate Helium Ion Beams: Minimizing Brain Tissue Damage while Preserving Tumor Control
Spatial and temporal transcriptomics of SHH-medulloblastoma with chromothripsis identifies multiple genetic clones that resist to treatment and lead to relapse
Neuroprotective Effects of Ultra-High Dose Rate FLASH Bragg Peak Proton Irradiation
Carbon ion irradiation plus CTLA4 blockade elicits therapeutic immune responses in a murine tumor model
Pharmacological Landscape of FDA-Approved Anticancer Drugs Reveals Sensitivities to Ixabepilone, Romidepsin, Omacetaxine, and Carfilzomib in Aggressive Meningiomas
Deep Learning–based Automatic Lung Segmentation on Multiresolution CT Scans from Healthy and Fibrotic Lungs in Mice
Simultaneous targeting of TGF-β/PD-L1 synergizes with radiotherapy by reprogramming the tumor microenvironment to overcome immune evasion
Carbon ion radiotherapy eradicates medulloblastomas with chromothripsis in an orthotopic Li-Fraumeni patient-derived mouse model
Receptor-Tyrosine Kinase Inhibitor Ponatinib Inhibits Meningioma Growth In Vitro and In Vivo
Photon versus carbon ion irradiation: immunomodulatory effects exerted on murine tumor cell lines
Late Intervention with Radiation-Induced Lung Fibrosis - Comparing Pamrevlumab Anti-CTGF Therapy vs. Pirfenidone vs. Nintedanib as Mono-, Dual- and Triple-therapy Combinations
Single Cell Transcriptomics Based Deconvolution Of Radiation Induced Lung Fibrosis (RILF) Model
Efficient Eradication of NSCLC by Combined DNAPK Inhibition and Carbon Ion Radiotherapy via Modulation of Tumor Invasion and Microenvironment - Beyond Direct Radiosensitization
Trimodal Therapy Consisting of DNA-PK Inhibition, PD-L1 Immune Checkpoint Blockade and Radiotherapy with Carbon Ions
Carbon irradiation overcomes glioma radioresistance by eradicating stem cells and forming an antiangiogenic and immunopermissive niche
Identification of KIF11 as a Novel Target in Meningioma
Relative Biological Effectiveness (RBE) for Development of Lung Fibrosis After Single Dose Carbon Ion Radiotherapy (CIRT)
Modeling and multiscale characterization of the quantitative imaging based fibrosis index reveals pathophysiological, transcriptome and proteomic correlates of lung fibrosis induced by fractionated irradiation
Determining RBE for development of lung fibrosis induced by fractionated irradiation with carbon ions utilizing fibrosis index and high-LET BED model
Quantitative assessment of radiation dose and fractionation effects on normal tissue by utilizing a novel lung fibrosis index model
Synergistic effects of crizotinib and radiotherapy in experimental EML4–ALK fusion positive lung cancer
Combined Inhibition of CTGF-Signaling and Radiation Therapy in Pancreatic Cancer
Comparison of Photon Versus Carbon Irradiation in Pancreatic Cancer